Literature DB >> 34289075

COVID-19 Vaccination in Haemodialysis Patients: Good things come in threes….

Luc Frantzen1,2, Sandrine Thibeaut3, Julie Moussi-Frances1,2, Monica Indreies1,2, Clotilde Kiener1,2, Yannick Saingra1,2, Julien Santini1,2, Paul Stroumza1,2, Yohan El-Haik4, Guilhem Cavaille1,2.   

Abstract

Entities:  

Year:  2021        PMID： 34289075     DOI： 10.1093/ndt/gfab224

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  9 in total

1. 

Authors:  Kevin Yau; Christopher T Chan; Kento T Abe; Yidi Jiang; Mohammad Atiquzzaman; Sarah I Mullin; Ellen Shadowitz; Lisa Liu; Ema Kostadinovic; Tatjana Sukovic; Anny Gonzalez; Margaret E McGrath-Chong; Matthew J Oliver; Jeffrey Perl; Jerome A Leis; Shelly Bolotin; Vanessa Tran; Adeera Levin; Peter G Blake; Karen Colwill; Anne-Claude Gingras; Michelle A Hladunewich
Journal:  CMAJ       Date:  2022-05-30       Impact factor: 16.859

2.  SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis.

Authors:  Pablo Garcia; Jialin Han; Maria E Montez-Rath; Sumi Sun; Tiffany Shang; Julie Parsonnet; Glenn M Chertow; Shuchi Anand; Brigitte Schiller; Graham Abra
Journal:  Clin J Am Soc Nephrol       Date:  2022-04-05       Impact factor: 10.614

3.  Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis.

Authors:  Caroline M Hsu; Eduardo K Lacson; Harold J Manley; Gideon N Aweh; Dana Miskulin; Doug Johnson; Daniel E Weiner
Journal:  Am J Kidney Dis       Date:  2022-04-01       Impact factor: 11.072

4.  Response to three doses of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine: a retrospective study of a cohort of haemodialysis patients in France.

Authors:  Jean-François Verdier; Sonia Boyer; Florence Chalmin; Ahmed Jeribi; Caroline Egasse; Marie France Maggi; Philippe Auvray; Tarik Yalaoui
Journal:  BMC Nephrol       Date:  2022-05-18       Impact factor: 2.585

5.  Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients.

Authors:  Jackrapong Bruminhent; Chavachol Setthaudom; Rungthiwa Kitpermkiat; Sasisopin Kiertiburanakul; Kumthorn Malathum; Montira Assanatham; Arkom Nongnuch; Angsana Phuphuakrat; Pongsathon Chaumdee; Chitimaporn Janphram; Sansanee Thotsiri; Piyatida Chuengsaman; Sarinya Boongird
Journal:  Sci Rep       Date:  2022-03-04       Impact factor: 4.379

Review 6.  COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.

Authors:  Khalil El Karoui; An S De Vriese
Journal:  Kidney Int       Date:  2022-02-14       Impact factor: 18.998

7.  Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease.

Authors:  Masatoshi Matsunami; Tomo Suzuki; Junko Fukuda; Toshiki Terao; Kohei Ukai; Shinnosuke Sugihara; Takumi Toishi; Kanako Nagaoka; Mayumi Nakata; Mamiko Ohara; Jun Yashima; Hiroshi Kuji; Kosei Matsue
Journal:  Ren Replace Ther       Date:  2022-04-05

8.  Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies.

Authors:  Niko Kohmer; Holger F Rabenau; Sandra Ciesek; Bernhard K Krämer; Uwe Göttmann; Christine Keller; Daniela Rose; Carsten Blume; Michael Thomas; Alexander Lammert; Anne Lammert
Journal:  Nephrol Dial Transplant       Date:  2022-05-25       Impact factor: 7.186

9.  Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis.

Authors:  Kevin Yau; Christopher T Chan; Kento T Abe; Yidi Jiang; Mohammad Atiquzzaman; Sarah I Mullin; Ellen Shadowitz; Lisa Liu; Ema Kostadinovic; Tatjana Sukovic; Anny Gonzalez; Margaret E McGrath-Chong; Matthew J Oliver; Jeffrey Perl; Jerome A Leis; Shelly Bolotin; Vanessa Tran; Adeera Levin; Peter G Blake; Karen Colwill; Anne-Claude Gingras; Michelle A Hladunewich
Journal:  CMAJ       Date:  2022-02-03       Impact factor: 16.859
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.